Source: Genes, Brain and Behavior. Unidade: FM
Subjects: FARMACOLOGIA (ESTUDO), FARMACOGENÉTICA, HIPERATIVIDADE
ABNT
BRUXEL, E. M. et al. LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study. Genes, Brain and Behavior, v. 14, n. 5, p. 419-427, 2015Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/gbb.12224/epdf. Acesso em: 28 out. 2024.APA
Bruxel, E. M., Salatino-Oliveira, A., Akutagava-Martins, G. C., Tovo-Rodrigues, L., Genro, J. P., Zeni, C. P., et al. (2015). LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study. Genes, Brain and Behavior, 14( 5), 419-427. doi:10.1111/gbb.12224NLM
Bruxel EM, Salatino-Oliveira A, Akutagava-Martins GC, Tovo-Rodrigues L, Genro JP, Zeni CP, Polanczyk GV, Chazan R, Schmitz M, Arcos-Burgos M, Rohde LA, Hutz MH. LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study [Internet]. Genes, Brain and Behavior. 2015 ; 14( 5): 419-427.[citado 2024 out. 28 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/gbb.12224/epdfVancouver
Bruxel EM, Salatino-Oliveira A, Akutagava-Martins GC, Tovo-Rodrigues L, Genro JP, Zeni CP, Polanczyk GV, Chazan R, Schmitz M, Arcos-Burgos M, Rohde LA, Hutz MH. LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study [Internet]. Genes, Brain and Behavior. 2015 ; 14( 5): 419-427.[citado 2024 out. 28 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/gbb.12224/epdf